Drug therapy for irritable bowel syndrome with constipation, 2022 AGA guideline recommendations at a glance
Time of Update: 2022-10-20
3. Recommended for IBS-C patients with Linaclotide (strongly recommended, high-quality evidence) Linaclotide is a short peptide containing 14 amino acids that, like pkanatide, binds to GC-C receptors on the surface of intestinal epithelial cells, resulting in intracellular and extracellular cyclic guanosine monophosphate ( cGMP) levels are elevated.
On August 5th, listed pharmaceutical companies announced review, increase and decrease of holdings, resignation, etc
Time of Update: 2022-08-15
[Pharmaceutical Network Industry News] On August 5, a large number of listed pharmaceutical companies issued announcements, involving matters such as over-evaluation, increase or decrease in holdings, and resignation.
One injection of 13.5 million yuan may cure SMA, the most expensive drug in history will land in China
Time of Update: 2022-05-03
Yangcheng Evening News reporter Zhang HuaRecently, the Center for Drug Evaluation (CDE) of China's State Food and Drug Administration announced that Novartis' AAV gene therapy drug Zolgensma (OAV101 injection) for the treatment of Spinal Muscular Atrophy (hereinafter referred to as "SMA") Drug clinical trial applications submitted in China have obtained implied permission for clinical trials .
Henan Provincial Key Laboratory of Brain-Targeted Bio-Nano Drugs published the latest GBM treatment research progress in ACS Nano and Journal of Controlled Release
Time of Update: 2022-04-19
The results were published in the journal ACS Nano as " Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy " .
132 large varieties of Chinese patent medicines are about to open bids
Time of Update: 2022-03-06
Guided by clinical needs, starting from high-priced and large-volume varieties, scientifically and prudently promote the reform of centralized procurement of Chinese patent medicines and formula granules .
The blockbuster centralized procurement alliance has landed, and the bid will be opened one month later
Time of Update: 2022-02-16
According to the document, the centralized procurement of drugs by the Yangtze River Delta Alliance involves 47 drugs including atorvastatin, entecavir, paroxetine, imatinib, and dapoxetine, all of which are domestically sourced .
There is a long way to fight against AIDS, how important is a safe treatment plan
Time of Update: 2022-01-10
On the basis of strong virus suppression, anti-AIDS drugs that have less toxic and side effects on various organs and tissues of the body, safe and easy to tolerate, and convenient to take have become an urgent need for HIV-infected people .
Traditional Chinese medicine decoction pieces are frequently found to be unqualified. How should pharmaceutical companies ensure quality and safety
Time of Update: 2021-11-14
Therefore, pharmaceutical equipment companies also need to continue to carry out technological innovation, while promoting the high-quality development of traditional Chinese medicine decoction pieces, continuously improve their own competitiveness .
Neurology: Zhejiang University: bilateral basal ganglia arteries are blocked, the earlier the treatment, the better the effect
Time of Update: 2021-11-01
In this way, Hongfei Sang and others of Zhejiang University used data from the BASILAR Endovascular Treatment Study for Acute Basilar Artery Occlusion (BASILAR) to evaluate how OPT affects the efficacy and safety of EVT in patients with acute BAO in current clinical practice .
Another AD drug
Time of Update: 2021-09-05
In June of this year, Aduhelm developed by Biogen and Eisai was approved by the FDA, becoming the first approved drug for Alzheimer's disease in the United States in the past 20 years .
J Hematol Oncol: PD-1 monoclonal antibody---the efficacy and safety of geptanolimab injection (geptanolimab) in peripheral T-cell lymphoma (PTCL
Time of Update: 2021-08-03
The study showed that geptanolimab injection (geptanolimab) has a significant effect in the treatment of patients with relapsed or refractory PTCL: the ORR assessed by IRC is 36.
The second domestic manufacturer of 8 billion insulin is coming to Dongyang Pharmaceutical to follow closely
Time of Update: 2021-08-02
Medical Network, July 14 hearing recently, Zhuhai United Laboratories' marketing applications for insulin aspart injection and insulin aspart 30 injection have entered the "under review" status and will soon be approved for listing .
The first KRAS inhibitor to receive accelerated approval from the US FDA for the treatment of non-small cell lung cancer
Time of Update: 2021-06-04
Pancreatic cancer and colorectal cancerStomach cancerRecently, the US Food and Drug Administration Board approved Lumakras (sotorasib) as a method for the treatment of adult patients with the first non-small cell lung cancer, tumors of these patients have a particular type of genetic mutation, known as KRAS G12C, and received at least once before System treatment.
Merck's PD-1, HER2, and chemotherapy triple therapy approved first-line treatment of gastric cancer | Yimai Meng broke the news
Time of Update: 2021-05-22
Nanjing JiangbeiThe annual event in the field of nucleic acid drugs is about to open ★One of the most popular research outlets!
Child epilepsy may affect brain development experts: pay attention to the golden period of treatment
Time of Update: 2021-04-13
Jiang Yuwu, director of the Pediatrics Department of Peking University First Hospital, said that epilepsy in infants and young children must be treated in a timely and formal manner to minimize or eliminate the adverse effects of epileptic encephalopathy on the normal development of children's brains.